Publications in collaboration with researchers from Universidad de Navarra (3)

2023

  1. AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability

    Brain, Behavior, and Immunity, Vol. 108, pp. 255-268

2021

  1. Opicapone for the treatment of Parkinson’s disease: real-life data in Spain

    Revista de Neurologia, Vol. 73, pp. S1-S14

  2. Predictors of clinically significant quality of life impairment in Parkinson’s disease

    npj Parkinson's Disease, Vol. 7, Núm. 1